Department of Justice
Drug Enforcement Administration
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 28, ( printed page 57623) 2000, Noramco, Inc., 1400 Olympic Drive, Athens, Georgia 30601, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:
The firm plans to support its other manufacturing facility with manufacturing and analytical testing.
Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.
Any such comments, or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than November 24, 2000.
| Drug | Schedule |
|---|---|
| Amphetamine (1100) | II |
| Codeine (9050) | II |
| Oxycodone (9143) | II |
| Hydrocodone (9193) | II |
| Morphine (9300) | II |
| Thebaine (9333) | II |
| Fentanyl (9801) | II |
Dated: September 6, 2000.
John H. King,
Deputy Assisatnt Administrator, Office of Diversion Control, Drug Enforcement Administration.